Publications by authors named "Ibrar Khaliq"
Article Synopsis
- The diagnosis of acute leukemia (AL) and myelodysplastic syndrome (MDS) is urgent due to their quick progression and differing survival rates among age groups, necessitating effective treatment strategies to lessen their global impact.
- Recent advancements in treatments like targeted therapies and immunotherapy show promise for better outcomes, especially for older patients.
- A systematic review evaluated 12 studies published from 2017 to 2024, highlighting improvements in diagnosis and management, but also pointing to ongoing challenges such as treatment costs and patient access.
Heart failure (HF) has become a global health threat, necessitating the development of novel treatment options to address this crisis. Sodium-glucose co-transporter-2 (SGLT2) inhibitors, such as dapagliflozin, may offer significant advantages in the treatment of HF, particularly in patients with reduced ejection fraction (HFrEF). This systematic review combines the findings from clinical studies to evaluate the safety and effectiveness of dapagliflozin in HF patients.
View Article and Find Full Text PDF